-
- 抗原 See all MEF2A 抗体
- MEF2A (Myocyte Enhancer Factor 2A (MEF2A))
-
抗原表位
- N-Term
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This MEF2A antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Immunofluorescence (IF), Immunocytochemistry (ICC), Immunohistochemistry (Whole Mount) (IHC (wm))
- 交叉反应
- 人, 斑马鱼
- 产品特性
-
Rabbit polyclonal antibody to MEF2A (myocyte enhancer factor 2A)
MEF2A antibody [N1N2], N-term - 纯化方法
- Purified by antigen-affinity chromatography.
- 免疫原
- Recombinant protein encompassing a sequence within the N-terminus region of human MEF2A. The exact sequence is proprietary.
- 亚型
- IgG
- Top Product
- Discover our top product MEF2A Primary Antibody
-
anti-Myocyte Enhancer Factor 2A (MEF2A) (pSer408) antibody
MEF2A 适用: 人, 小鼠, 大鼠 WB, ELISA, IHC (p), IF (p), IF (cc), IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-Myocyte Enhancer Factor 2A (MEF2A) (pThr312) antibodyMEF2A 适用: 人, 小鼠, 大鼠 WB, ELISA, IHC (p), IF (p), IF (cc), IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-Myocyte Enhancer Factor 2A (MEF2A) (AA 71-170) antibodyMEF2A 适用: 人 WB, ELISA, IF 宿主: 小鼠 Monoclonal 1F8 unconjugated
anti-Myocyte Enhancer Factor 2A (MEF2A) (AA 71-170) antibodyMEF2A 适用: 人 WB, ELISA, IF, IHC (p) 宿主: 小鼠 Monoclonal 1A10 unconjugated
anti-Myocyte Enhancer Factor 2A (MEF2A) (pThr319) antibodyMEF2A 适用: 人, 小鼠, 大鼠 WB, IHC, ELISA, IF, ICC 宿主: 兔 Polyclonal unconjugated
anti-Myocyte Enhancer Factor 2A (MEF2A) (C-Term) antibodyMEF2A 适用: 人 WB, IF, IHC (p), ICC 宿主: 兔 Polyclonal unconjugated
anti-Myocyte Enhancer Factor 2A (MEF2A) (AA 71-170) antibodyMEF2A 适用: 人 WB, ELISA, IHC (p) 宿主: 小鼠 Monoclonal 1D11 unconjugated
anti-Myocyte Enhancer Factor 2A (MEF2A) (pThr312) antibodyMEF2A 适用: 人, 小鼠, 大鼠 WB, IHC, ELISA, IF, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Myocyte Enhancer Factor 2A (MEF2A) (AA 391-497) antibodyMEF2A 适用: 人 ELISA 宿主: 小鼠 Monoclonal 2F9H2 unconjugated
anti-Myocyte Enhancer Factor 2A (MEF2A) (AA 466-507), (C-Term) antibodyMEF2A 适用: 人, 小鼠, 大鼠 WB, IHC (p) 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
- WB: 1:500-1:3000. ICC/IF: 1:100-1:1000. IHC-Wm: 1:100-1:500. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
- 说明
-
Positive Control: HeLa
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 0.77 mg/mL
- 缓冲液
- 0.1M Tris-Glycine ( pH 7), 10 % Glycerol, 0.01 % Thimerosal
- 储存液
- Thimerosal (Merthiolate)
- 注意事项
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 储存方法
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
- 抗原
- MEF2A (Myocyte Enhancer Factor 2A (MEF2A))
- 别名
- myocyte enhancer factor 2A (MEF2A 产品)
- 背景
-
The process of differentiation from mesodermal precursor cells to myoblasts has led to the discovery of a variety of tissue-specific factors that regulate muscle gene expression. The myogenic basic helix-loop-helix proteins, including myoD (MIM 159970), myogenin (MIM 159980), MYF5 (MIM 159990), and MRF4 (MIM 159991) are one class of identified factors. A second family of DNA binding regulatory proteins is the myocyte-specific enhancer factor-2 (MEF2) family. Each of these proteins binds to the MEF2 target DNA sequence present in the regulatory regions of many, if not all, muscle-specific genes. The MEF2 genes are members of the MADS gene family (named for the yeast mating type-specific transcription factor MCM1, the plant homeotic genes 'agamous' and 'deficiens' and the human serum response factor SRF (MIM 600589)), a family that also includes several homeotic genes and other transcription factors, all of which share a conserved DNA-binding domain.[supplied by OMIM]
Cellular Localization: Nucleus - 分子量
- 55 kDa
- 基因ID
- 4205
- UniProt
- Q02078
- 途径
- Neurotrophin Signaling Pathway, Activation of Innate immune Response, Carbohydrate Homeostasis, Chromatin Binding, Regulation of Muscle Cell Differentiation, Toll-Like Receptors Cascades
-
You are here:
